Topamax (topiramate) Tablets/Sprinkle Capsules - Dec 30, 2003
December 30, 2003
Audience: Neurologists and other Healthcare professionals
Ortho-McNeil and FDA revised the WARNINGS and PRECAUTIONS sections of the prescribing information, notifying healthcare professionals that Topamax causes hyperchloremic, non-anion gap metabolic acidosis (decreased serumbicarbonate). Measurement of baseline and periodic serum bicarbonate during topiramate treatment is recommended.
[December 2003
